Uniqure N.V. (QURE)

$22.84 +0.86 (3.91%)
Market Cap 1.39B
Revenue (ttm) 27.12M
Net Income (ttm) -239.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -883.33%
Debt to Equity Ratio 0.23
Volume 1,572,100
Avg Vol 2,912,466
Day's Range N/A - N/A
Shares Out 62.29M
Stochastic %K 11%
Beta 0.68
Analysts Strong Sell
Price Target $54.80

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
Reapthewhirlwind69
Reapthewhirlwind69 Jan. 16 at 3:07 PM
$QURE
0 · Reply
Ottoman_trader
Ottoman_trader Jan. 16 at 2:38 PM
$QURE we soon flying
0 · Reply
Dkll303
Dkll303 Jan. 16 at 1:37 PM
$QURE same day that Trump flipped the bird ! It was meant for Matt K , lol
0 · Reply
Dkll303
Dkll303 Jan. 16 at 1:36 PM
$QURE well you have en ex stockbroker as a CEO , what did you expect !!!! no science background, no PhD , just a street gangster at the helm , FDA knows it ! @FABATT
0 · Reply
FABATT
FABATT Jan. 16 at 1:15 PM
$QURE you can see as an example how long it takes for some companies to get the meeting after the initial pr announcement/release
0 · Reply
Src947
Src947 Jan. 15 at 6:41 PM
$QURE 5000 April 25 calls purchased
1 · Reply
kenny91655
kenny91655 Jan. 15 at 6:35 PM
$QURE When did they have the type-A meeting?
0 · Reply
OptionRunners
OptionRunners Jan. 15 at 6:10 PM
$QURE large call spread opening
0 · Reply
free2dream
free2dream Jan. 14 at 8:49 PM
$MRNA move your asks higher, they will come and get it. WATCH $SRPT and $QURE very nice REVERSALS , all seriously undervalued. $XBI $LABU
0 · Reply
JFais
JFais Jan. 14 at 4:52 PM
Only Wednesday and week's idea share/discussions covering quite a few tickers: $TGTX- suggestion subQ Briumvi not included in current valuation $QURE- summary from EHDN Europe webinar $HELP- could it be bigger than Spravato? $SLNO- more ppl warming up to on current weakness
0 · Reply
Latest News on QURE
uniQure Announces Type A Meeting Scheduled with FDA

Jan 9, 2026, 7:05 AM EST - 7 days ago

uniQure Announces Type A Meeting Scheduled with FDA

uniQure: Now What?

Jan 8, 2026, 3:36 PM EST - 8 days ago

uniQure: Now What?

What's Going On With uniQure Stock On Tuesday?

Dec 16, 2025, 12:17 PM EST - 4 weeks ago

What's Going On With uniQure Stock On Tuesday?

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Dec 7, 2025, 12:01 PM EST - 5 weeks ago

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Why uniQure Stock Is Trading Lower After FDA Meeting Update

Dec 4, 2025, 1:30 PM EST - 6 weeks ago

Why uniQure Stock Is Trading Lower After FDA Meeting Update

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Dec 4, 2025, 7:05 AM EST - 6 weeks ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Diamond Hill International Strategy Q3 2025 Performance Review

Nov 17, 2025, 8:59 AM EST - 2 months ago

Diamond Hill International Strategy Q3 2025 Performance Review

BABA HDB TSM

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 14, 2025, 4:17 AM EST - 2 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

Nov 12, 2025, 10:00 AM EST - 2 months ago

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

Nov 10, 2025, 12:44 PM EST - 2 months ago

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 11:11 AM EST - 2 months ago

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:05 AM EST - 2 months ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 2 months ago

uniQure to Announce Third Quarter 2025 Financial Results

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

Nov 3, 2025, 1:04 PM EST - 2 months ago

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

Nov 3, 2025, 10:01 AM EST - 2 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

Nov 3, 2025, 9:58 AM EST - 2 months ago

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

ABBV ALNY AMGN BMY LLY MBX MDGL

UniQure Stock Plummets 67% on Potential FDA Decision. Here's Why.

Nov 3, 2025, 8:11 AM EST - 2 months ago

UniQure Stock Plummets 67% on Potential FDA Decision. Here's Why.

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

Nov 3, 2025, 7:18 AM EST - 2 months ago

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade)

Oct 28, 2025, 1:55 PM EDT - 2 months ago

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade)

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood

Oct 8, 2025, 3:33 PM EDT - 3 months ago

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Sep 29, 2025, 4:05 PM EDT - 3 months ago

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

uniQure Announces Pricing of Upsized $300 Million Public Offering

Sep 25, 2025, 11:38 PM EDT - 4 months ago

uniQure Announces Pricing of Upsized $300 Million Public Offering

UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street

Sep 25, 2025, 8:37 AM EDT - 4 months ago

UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street

uniQure Stock Jumps On Positive News, But Risks Remain

Sep 25, 2025, 7:23 AM EDT - 4 months ago

uniQure Stock Jumps On Positive News, But Risks Remain

UniQure: How QURE Stock Rises 10x To $500?

Sep 25, 2025, 6:20 AM EDT - 4 months ago

UniQure: How QURE Stock Rises 10x To $500?

Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it

Sep 24, 2025, 4:37 PM EDT - 4 months ago

Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it

uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond

Sep 24, 2025, 4:24 PM EDT - 4 months ago

uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond

uniQure Announces $200 Million Proposed Public Offering

Sep 24, 2025, 4:06 PM EDT - 4 months ago

uniQure Announces $200 Million Proposed Public Offering

uniQure N.V. - Special Call

Sep 24, 2025, 1:03 PM EDT - 4 months ago

uniQure N.V. - Special Call

QURE stock skyrockets 200% on ‘three' big news

Sep 24, 2025, 11:20 AM EDT - 4 months ago

QURE stock skyrockets 200% on ‘three' big news

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

Sep 24, 2025, 10:23 AM EDT - 4 months ago

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

UniQure's brain disorder drug slows disease progression in trial

Sep 24, 2025, 7:28 AM EDT - 4 months ago

UniQure's brain disorder drug slows disease progression in trial

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

Sep 24, 2025, 7:10 AM EDT - 4 months ago

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's Disease

Sep 24, 2025, 7:05 AM EDT - 4 months ago

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's Disease

uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data

Sep 5, 2025, 4:57 PM EDT - 4 months ago

uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Sep 5, 2025, 7:05 AM EDT - 4 months ago

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Jul 30, 2025, 11:07 AM EDT - 6 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA RCKT

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 9:07 PM EDT - 6 months ago

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Jul 29, 2025, 7:05 AM EDT - 6 months ago

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 7:05 AM EDT - 6 months ago

uniQure to Announce Second Quarter 2025 Financial Results

uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer

Jun 11, 2025, 8:00 AM EDT - 7 months ago

uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer

uniQure's AMT-130 Gene Therapy Warrants An Upgrade

May 28, 2025, 4:56 AM EDT - 8 months ago

uniQure's AMT-130 Gene Therapy Warrants An Upgrade

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

May 19, 2025, 8:00 AM EDT - 8 months ago

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

AKTX CRBP

uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:16 PM EDT - 8 months ago

uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript

Reapthewhirlwind69
Reapthewhirlwind69 Jan. 16 at 3:07 PM
$QURE
0 · Reply
Ottoman_trader
Ottoman_trader Jan. 16 at 2:38 PM
$QURE we soon flying
0 · Reply
Dkll303
Dkll303 Jan. 16 at 1:37 PM
$QURE same day that Trump flipped the bird ! It was meant for Matt K , lol
0 · Reply
Dkll303
Dkll303 Jan. 16 at 1:36 PM
$QURE well you have en ex stockbroker as a CEO , what did you expect !!!! no science background, no PhD , just a street gangster at the helm , FDA knows it ! @FABATT
0 · Reply
FABATT
FABATT Jan. 16 at 1:15 PM
$QURE you can see as an example how long it takes for some companies to get the meeting after the initial pr announcement/release
0 · Reply
Src947
Src947 Jan. 15 at 6:41 PM
$QURE 5000 April 25 calls purchased
1 · Reply
kenny91655
kenny91655 Jan. 15 at 6:35 PM
$QURE When did they have the type-A meeting?
0 · Reply
OptionRunners
OptionRunners Jan. 15 at 6:10 PM
$QURE large call spread opening
0 · Reply
free2dream
free2dream Jan. 14 at 8:49 PM
$MRNA move your asks higher, they will come and get it. WATCH $SRPT and $QURE very nice REVERSALS , all seriously undervalued. $XBI $LABU
0 · Reply
JFais
JFais Jan. 14 at 4:52 PM
Only Wednesday and week's idea share/discussions covering quite a few tickers: $TGTX- suggestion subQ Briumvi not included in current valuation $QURE- summary from EHDN Europe webinar $HELP- could it be bigger than Spravato? $SLNO- more ppl warming up to on current weakness
0 · Reply
Thinkingman91
Thinkingman91 Jan. 14 at 2:27 PM
$QURE they look like higher lows to me
0 · Reply
njohnson55
njohnson55 Jan. 14 at 11:51 AM
$QURE
0 · Reply
njohnson55
njohnson55 Jan. 14 at 11:40 AM
$QURE
0 · Reply
Masonsy
Masonsy Jan. 14 at 12:34 AM
$QURE at a point of time, we have to accept the reality that Phase 3 - RCT is required before regulatory approval.
0 · Reply
N3rd4You
N3rd4You Jan. 13 at 11:32 PM
$QURE lives are going to be saved
0 · Reply
InvestorNOR
InvestorNOR Jan. 13 at 9:15 PM
$QURE Potential revisit to $19
0 · Reply
murphylaw
murphylaw Jan. 13 at 7:10 PM
$QURE back to $50 by end of Q1.
0 · Reply
buymoremakemore
buymoremakemore Jan. 13 at 6:23 PM
$QURE Bought In. Bottom soon
0 · Reply
freddie04
freddie04 Jan. 13 at 3:25 PM
$QURE $13 incoming
0 · Reply
Tdorsey1776
Tdorsey1776 Jan. 13 at 3:23 PM
$QURE B 2500 @ $21.585....DUE for a bounce
0 · Reply
freddie04
freddie04 Jan. 13 at 2:47 PM
$CADL RED ..right !!! Why of course…said the market maker We can’t sell this crap to anyone with a brain !! But we have a special , going on for another failed biotech $QURE …DOWN over 50% from its high !! If neither ….I have an island for sale, they call it Epstein
0 · Reply
rml360
rml360 Jan. 13 at 2:29 PM
$QURE buying more this morning, expecting 24+
1 · Reply